Quest Partners LLC
- SEC CIK
- 0001883897
- Latest filing
- Aug 7, 2026
ENTA holding history
Enanta Pharmaceuticals Inc in every 13F filed by Quest Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENTA overviewAll 13F holders of ENTAFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −14,178−100.0% | Sold out | Holders |
| Q4 2025 | 14,178 | $223.6K | <0.1% | +3,980+39.0% | Added | Holders |
| Q3 2025 | 10,198 | $122.1K | <0.1% | +1,562+18.1% | Added | Holders |
| Q2 2025 | 8,636 | $65.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 8,636 | $47.7K | <0.1% | −13,624−61.2% | Reduced | Holders |
| Q4 2024 | 22,260 | $128.0K | <0.1% | +3,137+16.4% | Added | Holders |
| Q3 2024 | 19,123 | $198.1K | <0.1% | +7,535+65.0% | Added | Holders |
| Q2 2024 | 11,588 | $150.3K | <0.1% | +9,692+511.2% | Added | Holders |
| Q1 2024 | 1,896 | $33.1K | <0.1% | −13,569−87.7% | Reduced | Holders |
| Q4 2023 | 15,465 | $145.5K | <0.1% | – | No prior filing | Holders |